Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FFBR1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,574
Award facts
- Contract value 100% obligated
- $26,574.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $26,574 to DMS Pharmaceutical Group Inc. for Mirena 52 mg contraceptive systems. The award, issued on December 15, 2025, with an ultimate completion date of January 7, 2026, represents a single delivery order with no set-aside designation, meaning the contract was competed among all eligible vendors. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the prime contractor with no identified subcontractors. The place of performance is located in Park Ridge, IL.
This delivery order is issued under DMS Pharmaceutical Group's umbrella Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. That parent contract, valued at approximately $500 million with a completion date of December 31, 2036, positions the company as a critical regional pharmaceutical supplier for Department of Defense military healthcare facilities worldwide. The PPV-G GEN V program represents part of the DLA's broader $30.3 billion pharmaceutical supply strategy, enabling the issuance of delivery orders for branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring medical supply needs across the federal military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FFBR1?
SPE2DR26FFBR1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FFBR1 worth?
The government has obligated $26,574 on SPE2DR26FFBR1.
Is contract SPE2DR26FFBR1 an order under another contract?
Yes. SPE2DR26FFBR1 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBR1 competed?
The extent of competition for SPE2DR26FFBR1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award